Literature DB >> 30201809

Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.

Jennie A Hamilton1, Qi Wu1, PingAr Yang1, Bao Luo1, Shanrun Liu1, Jun Li1, Alexa L Mattheyses2, Ignacio Sanz3, W Winn Chatham1, Hui-Chen Hsu1, John D Mountz4,5.   

Abstract

In systemic lupus erythematosus (SLE), type I IFNs promote induction of type I IFN-stimulated genes (ISG) and can drive B cells to produce autoantibodies. Little is known about the expression of distinct type I IFNs in lupus, particularly high-affinity IFN-β. Single-cell analyses of transitional B cells isolated from SLE patients revealed distinct B cell subpopulations, including type I IFN producers, IFN responders, and mixed IFN producer/responder clusters. Anti-Ig plus TLR3 stimulation of SLE B cells induced release of bioactive type I IFNs that could stimulate HEK-Blue cells. Increased levels of IFN-β were detected in circulating B cells from SLE patients compared with controls and were significantly higher in African American patients with renal disease and in patients with autoantibodies. Together, the results identify type I IFN-producing and -responding subpopulations within the SLE B cell compartment and suggest that some patients may benefit from specific targeting of IFN-β.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201809      PMCID: PMC6230322          DOI: 10.4049/jimmunol.1800791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations.

Authors:  Shruti Sharma; Zhongbo Jin; Elizabeth Rosenzweig; Swapna Rao; Kichul Ko; Timothy B Niewold
Journal:  J Autoimmun       Date:  2015-04-24       Impact factor: 7.094

2.  Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.

Authors:  Lin Gao; Anna K Bird; Nida Meednu; Kristin Dauenhauer; Jane Liesveld; Jennifer Anolik; R John Looney
Journal:  Arthritis Rheumatol       Date:  2017-07-11       Impact factor: 10.995

3.  Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus.

Authors:  Hao Li; Yang-Xin Fu; Qi Wu; Yong Zhou; David K Crossman; PingAr Yang; Jun Li; Bao Luo; Laurence M Morel; Janusz H Kabarowski; Hideo Yagita; Carl F Ware; Hui-Chen Hsu; John D Mountz
Journal:  J Clin Invest       Date:  2015-06-22       Impact factor: 14.808

4.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

5.  Type I IFN induction in response to Listeria monocytogenes in human macrophages: evidence for a differential activation of IFN regulatory factor 3 (IRF3).

Authors:  Thornik Reimer; Matthias Schweizer; Thomas W Jungi
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

6.  Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Robert D Schreiber; Brian R Lawson; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2012-11-21       Impact factor: 5.422

7.  Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure.

Authors:  Anna M Gram; Chenglong Sun; Sanne L Landman; Timo Oosenbrug; Hester J Koppejan; Mark J Kwakkenbos; Rob C Hoeben; Søren R Paludan; Maaike E Ressing
Journal:  Mol Immunol       Date:  2017-09-30       Impact factor: 4.407

8.  ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap.

Authors:  Tauno Metsalu; Jaak Vilo
Journal:  Nucleic Acids Res       Date:  2015-05-12       Impact factor: 16.971

9.  Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.

Authors:  Paul A Lyons; Eoin F McKinney; Tim F Rayner; Alexander Hatton; Hayley B Woffendin; Maria Koukoulaki; Thomas C Freeman; David R W Jayne; Afzal N Chaudhry; Kenneth G C Smith
Journal:  Ann Rheum Dis       Date:  2009-10-07       Impact factor: 19.103

10.  Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.

Authors:  Kichul Ko; Yelena Koldobskaya; Elizabeth Rosenzweig; Timothy B Niewold
Journal:  Front Immunol       Date:  2013-10-01       Impact factor: 7.561

View more
  9 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

Review 2.  Autoreactive B cells in SLE, villains or innocent bystanders?

Authors:  Jennie A Hamilton; Hui-Chen Hsu; John D Mountz
Journal:  Immunol Rev       Date:  2019-10-21       Impact factor: 12.988

3.  Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.

Authors:  Yannick Dieudonné; Vincent Gies; Aurélien Guffroy; Céline Keime; Anna K Bird; Jane Liesveld; Jennifer L Barnas; Vincent Poindron; Nawal Douiri; Pauline Soulas-Sprauel; Thierry Martin; Eric Meffre; Jennifer H Anolik; Anne-Sophie Korganow
Journal:  J Autoimmun       Date:  2019-05-10       Impact factor: 7.094

Review 4.  The Plasticity of Newly Formed B Cells.

Authors:  Natalia V Giltiay; Daniela Giordano; Edward A Clark
Journal:  J Immunol       Date:  2019-12-15       Impact factor: 5.422

5.  High TLR7 Expression Drives the Expansion of CD19+CD24hiCD38hi Transitional B Cells and Autoantibody Production in SLE Patients.

Authors:  Ting Wang; John Marken; Janice Chen; Van Bao Tran; Quan-Zhen Li; Mengtao Li; Karen Cerosaletti; Keith B Elkon; Xiaofeng Zeng; Natalia V Giltiay
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 6.  Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.

Authors:  I-Tsu Chyuan; Hong-Tai Tzeng; Ji-Yih Chen
Journal:  Cells       Date:  2019-08-23       Impact factor: 6.600

7.  Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study.

Authors:  Fatima Alduraibi; Huma Fatima; Jennie A Hamilton; W Winn Chatham; Hui-Chen Hsu; John D Mountz
Journal:  Arthritis Res Ther       Date:  2022-04-18       Impact factor: 5.606

8.  CD4+ T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE.

Authors:  Kittikorn Wangriatisak; Piyawan Kochayoo; Pongsakorn Thawornpan; Chaniya Leepiyasakulchai; Thanitta Suangtamai; Pintip Ngamjanyaporn; Ladawan Khowawisetsut; Prasong Khaenam; Prapaporn Pisitkun; Patchanee Chootong
Journal:  Lupus Sci Med       Date:  2022-09

9.  Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study.

Authors:  Joel M Guthridge; Rufei Lu; Ly Thi-Hai Tran; Cristina Arriens; Teresa Aberle; Stan Kamp; Melissa E Munroe; Nicolas Dominguez; Timothy Gross; Wade DeJager; Susan R Macwana; Rebecka L Bourn; Stephen Apel; Aikaterini Thanou; Hua Chen; Eliza F Chakravarty; Joan T Merrill; Judith A James
Journal:  EClinicalMedicine       Date:  2020-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.